GRAIL, Inc. (GRAL)
138.92
+1.55
(+1.13%)
USD |
NASDAQ |
Oct 13, 09:44
GRAIL Price to Book Value : 2.440 for Oct. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 2.413 |
| October 09, 2026 | 2.470 |
| October 08, 2026 | 2.330 |
| October 07, 2026 | 2.335 |
| October 06, 2026 | 2.412 |
| October 05, 2026 | 2.707 |
| October 02, 2026 | 2.517 |
| October 01, 2026 | 2.329 |
| September 30, 2026 | 2.462 |
| September 29, 2026 | 2.399 |
| September 28, 2026 | 2.330 |
| September 25, 2026 | 2.229 |
| September 24, 2026 | 2.200 |
| September 23, 2026 | 1.906 |
| September 22, 2026 | 1.906 |
| September 21, 2026 | 1.897 |
| September 18, 2026 | 1.419 |
| September 17, 2026 | 1.404 |
| September 16, 2026 | 1.319 |
| September 15, 2026 | 1.333 |
| September 14, 2026 | 1.327 |
| September 11, 2026 | 1.339 |
| September 10, 2026 | 1.362 |
| September 09, 2026 | 1.361 |
| September 08, 2026 | 1.390 |
| Date | Value |
|---|---|
| September 04, 2026 | 1.411 |
| September 03, 2026 | 1.416 |
| September 02, 2026 | 1.415 |
| September 01, 2026 | 1.402 |
| August 31, 2026 | 1.394 |
| August 28, 2026 | 1.405 |
| August 27, 2026 | 1.449 |
| August 26, 2026 | 1.398 |
| August 25, 2026 | 1.45 |
| August 24, 2026 | 1.345 |
| August 21, 2026 | 1.397 |
| August 20, 2026 | 1.370 |
| August 19, 2026 | 1.299 |
| August 18, 2026 | 1.245 |
| August 17, 2026 | 1.229 |
| August 14, 2026 | 1.192 |
| August 13, 2026 | 1.199 |
| August 12, 2026 | 1.211 |
| August 11, 2026 | 1.326 |
| August 10, 2026 | 1.315 |
| August 07, 2026 | 1.220 |
| August 06, 2026 | 1.114 |
| August 05, 2026 | 1.303 |
| August 04, 2026 | 1.277 |
| August 03, 2026 | 1.234 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Moderna, Inc. | 12.59 |
| Twist Bioscience Corp. | 21.21 |
| Prime Medicine, Inc. | 16.12 |
| Kailera Therapeutics, Inc. | 1.298 |
| Arrowhead Pharmaceuticals, Inc. | 18.16 |
Price to Book Value Related Metrics
| PS Ratio | 33.75 |
| Price | 138.92 |
| Earnings Yield | -7.02% |
| Market Cap | 6.205B |